Amarin Corp Plcuk (AMRN) Non-Current Deffered Revenue (2015 - 2024)

Amarin Corp Plcuk (AMRN) posted quarterly Non-Current Deffered Revenue of $2.1 million for Q1 2024, down 83.4% YoY from $12.7 million in Q2 2023, and down 15.98% sequentially from $2.5 million in Q4 2023.

Amarin Corp Plcuk (AMRN) Non-Current Deffered Revenue (2015 - 2024) Analysis & Trends

Amarin Corp Plcuk has disclosed Non-Current Deffered Revenue across 10 years of filings, most recently posting $2.1 million for Q1 2024.

  • In Q1 2024, Non-Current Deffered Revenue fell 83.4% year-over-year to $2.1 million; the TTM figure through Mar 2024 stood at $2.1 million (down 83.4% YoY), while the FY2023 annual figure was $2.5 million, down 80.92% from the prior year.
  • Non-Current Deffered Revenue eased to $2.1 million in Q1 2024, from $2.5 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for AMRN reached as high as $17.5 million in Q1 2020 and fell as low as $2.1 million in Q1 2024.
  • The 5-year median for Non-Current Deffered Revenue is $13.8 million (2022), against an average of $11.6 million.
  • Annual changes were most pronounced in 2021 — Non-Current Deffered Revenue rose 9.75% — and 2024, when it slumped 83.4%.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $15.7 million in 2020, then dropped by 10.48% to $14.1 million in 2021, then declined by 6.49% to $13.1 million in 2022, then tumbled by 80.92% to $2.5 million in 2023, then declined by 15.98% to $2.1 million in 2024.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.1 million, $2.5 million, and $2.9 million for Q1 2024, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 2.11 Mn
Dec 31, 2023 2.51 Mn
Sep 30, 2023 2.95 Mn
Jun 30, 2023 3.33 Mn
Mar 31, 2023 12.70 Mn
Dec 31, 2022 13.15 Mn
Sep 30, 2022 13.50 Mn
Jun 30, 2022 13.81 Mn
Mar 31, 2022 14.14 Mn
Dec 31, 2021 14.06 Mn
Sep 30, 2021 14.49 Mn
Jun 30, 2021 14.83 Mn
Mar 31, 2021 15.20 Mn
Dec 31, 2020 15.71 Mn
Sep 30, 2020 13.20 Mn
Jun 30, 2020 14.51 Mn
Mar 31, 2020 17.52 Mn
Dec 31, 2019 18.50 Mn
Sep 30, 2019 17.62 Mn
Jun 30, 2019 17.78 Mn